Risk of not receiving 2nd line therapy is high in EGFR mt plus patients: Real world data of certified lung cancer centers on treatment sequence in EGFR mt plus patients
Journal article published in 2018 by
J. Roeper,
M. Falk,
S. Schatz,
M. Tiemann,
C. Wesseler 
,
G. Wiest,
S. Sackmann,
D. Ukena,
L. Heukamp,
F. Griesinger
,
G. Wiest,
S. Sackmann,
D. Ukena,
L. Heukamp,
F. Griesinger
